Home

The Edwards Sapien 3 transcatheter pulmonary valve (TPV) system combines the proven Sapien 3 transcatheter heart valve and the Alterra adaptive prestent to expand transcatheter therapy options for congenital heart valve disease patients, Edwards said in a press release. The Alterra prestent compensates for variations in size and morphology of the right ventricular outflow tract to provide a stable landing zone for the Sapien 3 valve.

“The FDA approval of the Sapien 3 with Alterra is great news for patients around the world, many of whom have endured numerous surgical procedures to treat their congenital heart disease,” said Evan Zahn, director of Guerin Family Congenital Heart Program at the Smidt Heart Institute, Cedars-Sinai Medical Center (Los Angeles, USA), and principal investigator for the ALTERRA clinical trial. “The outstanding outcomes achieved by Sapien 3 with Alterra will expand the range of patients who require pulmonary valve replacement that we can now treat with minimally invasive therapy. This will result in significant improvements in quality of life and a reduction in the number of surgeries and procedures that a congenital heart patient requires over the course of their lifetime.”

While pulmonic heart valve replacements represent a small fraction of the heart valve replacements done each year, it is generally required to replace valves in adolescent and adult patients suffering from Tetralogy of Fallot or other congenital heart valve defects.

“I am very proud of this advancement, which exemplifies the important work of our team at Edwards to develop life-saving innovations addressing urgent needs of this important patient group,” said Larry Wood, corporate vice president, transcatheter aortic valve replacement, Edwards Lifesciences. “Many of these patients endure repeated open-heart surgeries to address heart conditions present since birth, which takes a huge toll on their ability to lead normal lives. The Sapien 3 with Alterra provides a new treatment option that can reduce the number of invasive procedures these patients face in their lifetimes.”

The Edwards Sapien 3 TPV system with Alterra adaptive prestent is indicated for use in the management of paediatric and adult patients with severe pulmonary regurgitation as measured by echocardiography, who have a native or surgically repaired right ventricular outflow tract and are clinically indicated for surgical pulmonary valve replacement.

Source CardiovascularNews

Duc Tin Clinic

Chia sẽ qua facebook bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua google bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua twitter bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua MySpace bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua LinkedIn bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua stumbleupon bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua icio bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua digg bài: Sapien 3 with Alterra present gains FDA approval

Chia sẽ qua yahoo bài: Sapien 3 with Alterra present gains FDA approval

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.